IC43 + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pneumonia, Ventilator-Associated
Conditions
Pneumonia, Ventilator-Associated
Trial Timeline
Dec 1, 2008 → Feb 1, 2010
NCT ID
NCT00876252About IC43 + Placebo
IC43 + Placebo is a phase 2 stage product being developed by Valneva SE for Pneumonia, Ventilator-Associated. The current trial status is completed. This product is registered under clinical trial identifier NCT00876252. Target conditions include Pneumonia, Ventilator-Associated.
What happened to similar drugs?
20 of 20 similar drugs in Pneumonia, Ventilator-Associated were approved
Approved (20) Terminated (4) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01563263 | Phase 2/3 | Completed |
| NCT00876252 | Phase 2 | Completed |
| NCT00778388 | Phase 1 | Completed |
Competing Products
20 competing products in Pneumonia, Ventilator-Associated